Chris Wolski - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Chris Wolski's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Chris Wolski

Chris Wolski

Verified

Chief Editor, Clinical Lab Products

Los Angeles

Final Covers

Pharmaceutical news, Healthcare PolicyAnesthesiology, Pain Medicine Regional Anesthesia, FDA device and drugs approvals

Doesn’t Cover

I am not a political news reporter.

Journalist Type

-

Seniority Positions

Industries

Medium Formats

-

Content

Total articles 1310

  • MSDA Test Provides Clinically Actionable Insights

    By Chris Wolski| Clinical Lab Products Verified One-sentence summary:Octave Bioscience’s real-world study demonstrates that its clinically validated MSDA Test significantly enhances clinical decision-making in managing multiple sclerosis by providing reliable, multi-protein biomarker data on disease activity. • High clinical impact: The MSDA Test influenced MS treatment decisions in nearly 60% of cases, rising to over 69% with repeated use.

    By Chris Wolski · Clinical Lab Products

    Apr. 17, 2025

  • DNA Methylation Entropy Can Be Used to Track Aging

    By Chris Wolski| Clinical Lab Products Verified One-sentence summary:Researchers at UCLA identified DNA methylation entropy as a new and accurate biomarker for aging, offering deeper insight into epigenetic changes over time. Three brief takeaways:Methylation entropy reflects the randomness in DNA chemical tags and changes predictably with age. It predicts biological age as accurately as traditional methods and improves further when combined with other markers.

    By Chris Wolski · Clinical Lab Products

    Apr. 16, 2025

  • MSDA Test Provides Clinically Actionable Insights

    By Chris Wolski| Clinical Lab Products Verified One-sentence summary:Octave Bioscience’s real-world study demonstrates that its clinically validated MSDA Test significantly enhances clinical decision-making in managing multiple sclerosis by providing reliable, multi-protein biomarker data on disease activity. • High clinical impact: The MSDA Test influenced MS treatment decisions in nearly 60% of cases, rising to over 69% with repeated use.

    By Chris Wolski · Clinical Lab Products

    Apr. 17, 2025

As seen in

Company Info

Clinical Lab Products

Clinical Lab Products (CLP), under the MEDQOR brand, is a dedicated media platform for the clinical laboratory industry. It provides valuable resources for professionals by offering comprehensive coverage of diagnostic technologies, product innovations, and industry trends. CLP delivers editorial content through monthly print magazines and e-newsletters that analyze product developments and best practices. It also features a Resource Center with webinars and expert discussions on relevant topics, such as Anti-Xa assay testing. The platform reaches over 40,000 decision-makers, including pathologists, lab managers, and technologists, ensuring that its content supports informed decision-making in clinical laboratories. As part of MEDQOR’s Clinical Laboratory Division, CLP collaborates with industry experts to maintain its position as a leading source of news and insights in clinical lab technology.

Los Angeles, United States

+1 310-642-4400